Virobay Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Out of Business

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Out of Business

Virobay General Information

Description

Provider of a cysteine cathepsin platform designed to develop and commercialize novel drugs. The company's platform focuses on addressing significant unmet medical needs for the treatment of neuropathic pain, autoimmune diseases and fibrosis and develop safer and more effective therapies for these diseases, enabling patients to get enzyme treatments that regulate essential processes in cells by cleaving certain proteins.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1360 Willow Road
  • Suite 100
  • Menlo Park, CA 94025
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • 1360 Willow Road
  • Suite 100
  • Menlo Park, CA 94025
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Virobay Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 25-Sep-2018 Completed Out of Business
4. Secondary Transaction - Private Completed Generating Revenue
3. IPO 20-Oct-2014 Cancelled Generating Revenue
2. Later Stage VC (Series B) 16-Jul-2014 $18M $48M Completed Generating Revenue
1. Early Stage VC (Series A) 18-Aug-2006 $30M $30M Completed Startup
To view Virobay’s complete valuation and funding history, request access »

Virobay Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Virobay’s complete cap table history, request access »

Virobay Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of a cysteine cathepsin platform designed to develop and commercialize novel drugs. The company's platform focu
Drug Discovery
Menlo Park, CA
6 As of 2016

Shelton, CT
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Virobay Competitors (49)

One of Virobay’s 49 competitors is Nanoviricides, a Corporation company based in Shelton, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nanoviricides Corporation Shelton, CT
Genentech Formerly VC-backed South San Francisco, CA
Renova Therapeutics Venture Capital-Backed Carlsbad, CA
Anavex Life Sciences Corporation New York, NY
Innovimmune Biotherapeutics Accelerator/Incubator Backed New York, NY
You’re viewing 5 of 49 competitors. Get the full list »

Virobay Patents

Virobay Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2014189646-A1 Processes and intermediates useful for preparing cysteine protease inhibitors Inactive 24-May-2013
WO-2014153113-A2 Processes and intermediates for the preparation of 3 amino-n-cyclopropyl-2 hydroxypropionamide derivatives Inactive 14-Mar-2013
WO-2014153113-A3 Processes and intermediates for the preparation of 3 amino-n-cyclopropyl-2 hydroxypropionamide derivatives Inactive 14-Mar-2013
US-20140256698-A1 Cathepsin inhibitors Inactive 11-Mar-2013
US-20150191459-A1 Cathepsin inhibitors Inactive 11-Mar-2013 C07D413/12
To view Virobay’s complete patent history, request access »

Virobay Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Virobay FAQs

  • When was Virobay founded?

    Virobay was founded in 2006.

  • Where is Virobay headquartered?

    Virobay is headquartered in Menlo Park, CA.

  • What is the size of Virobay?

    Virobay has 6 total employees.

  • What industry is Virobay in?

    Virobay’s primary industry is Drug Discovery.

  • Is Virobay a private or public company?

    Virobay is a Private company.

  • What is Virobay’s current revenue?

    The current revenue for Virobay is .

  • How much funding has Virobay raised over time?

    Virobay has raised $48M.

  • Who are Virobay’s competitors?

    Nanoviricides, Genentech, Renova Therapeutics, Anavex Life Sciences, and Innovimmune Biotherapeutics are some of the 49 competitors of Virobay.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process